MISSION PHARMACAL
LIVE

Serial Number

75338602

Owner

MISSION PHARMACAL COMPANY

Attorney

Pamela B. Huff

First Use Date

Jan 1, 1996

Filing Date

Aug 11, 1997

Add to watchlist:

No watchlists yet
View on USPTO

MISSION PHARMACAL Trademark

Serial Number: 75338602 • Registration: 2189371

MISSION PHARMACAL is a trademark filed by MISSION PHARMACAL COMPANY on August 11, 1997. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

MISSION PHARMACAL COMPANY (377 trademarks)

8000 Interstate Highway 10 West
SAN ANTONIO, TX 78230

Entity Type: 03

Trademark Details

Filing Date

August 11, 1997

Registration Date

September 15, 1998

First Use Anywhere

January 1, 1996

First Use in Commerce

January 1, 1996

Published for Opposition

June 23, 1998

Goods & Services

pharmaceutical products, namely, prophylactic drugs preventing calcium absorption by the human body, therapeutic multivitamin combinations, orally administered dietary supplements of calcium salt, orally administered dietary supplements of calcium salt with vitamin D, laxatives, analgesic preparations for internal use or topical application, antacid tablets for gastric hyperacidity, antispasmodic treatments, hematinic tablets of ferrous gluconate, therapeutic flouride, folic acid tablets, preparations for prevention and relief of complications of pregnancy and lactation resulting from inadequate nutrition and imbalance, orally administered sodium salt tablets, high carbohydrate protein dietary food supplements, preparations for the treatment of secondary anemia, pharmaceutical preparations in chewable tablet dosage form, namely, antispasmodic, anticholinergics, antacids, antihistamines, antibiotics, antiasmatics and antinauseas, for dietary supplements as a magnesium and citrate inhibitor indicated as prophylactic for recurring kidney stones, for surgical lubricating jelly, vitamin and mineral preparations in liquid tablet and capsule form, slow-release salt tablets, prophylactic and treatment drug of potassium citrate embodied in slow-release wax matrix to prevent or dissolve kidney stones, orally administered potassium phosphate preparations utilized for treatment of kidney stones, pharmacuetical products prepared as an appetite depressant

Filing History

TEAS CHANGE OF CORRESPONDENCE RECEIVED
Mar 27, 2025 TCCA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Mar 27, 2025 ARAA
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Mar 27, 2025 REAP
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Mar 27, 2025 CHAN
TEAS CHANGE OF OWNER ADDRESS RECEIVED
Mar 27, 2025 COAR
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Mar 3, 2021 ASCK
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
May 18, 2018 NA89
REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
May 18, 2018 RNL2
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
May 18, 2018 89AG
CORRECTION UNDER SECTION 7 - PROCESSED
May 18, 2018 COC.
TEAS SECTION 7 REQUEST RECEIVED
May 4, 2018 ES7R
POST REGISTRATION ACTION MAILED - SEC. 8 & 9
Mar 19, 2018 PR89
TEAS SECTION 8 & 9 RECEIVED
Mar 13, 2018 E89R
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
Sep 15, 2017 REM2
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Jul 7, 2017 TCCA
CASE FILE IN TICRS
May 16, 2011 CFIT
CASE FILE IN TICRS
Apr 18, 2011 CFIT
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
Aug 29, 2008 RNL1
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
Aug 29, 2008 89AG
ASSIGNED TO PARALEGAL
Aug 28, 2008 PLGL
TEAS SECTION 8 & 9 RECEIVED
Aug 21, 2008 E89R
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
Aug 23, 2004 C15A
REGISTERED - SEC. 8 (6-YR) & SEC. 15 FILED
Jul 19, 2004 815F
TEAS SECTION 8 & 15 RECEIVED
Jul 19, 2004 E815
TEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 21, 2003 TCCA
PAPER RECEIVED
Nov 7, 2002 MAIL
REGISTERED-PRINCIPAL REGISTER
Sep 15, 1998 R.PR
PUBLISHED FOR OPPOSITION
Jun 23, 1998 PUBO
NOTICE OF PUBLICATION
May 22, 1998 NPUB
APPROVED FOR PUB - PRINCIPAL REGISTER
Apr 10, 1998 CNSA
EXAMINER'S AMENDMENT MAILED
Apr 6, 1998 CNEA
ASSIGNED TO EXAMINER
Mar 23, 1998 DOCK
ASSIGNED TO EXAMINER
Mar 23, 1998 DOCK
ASSIGNED TO EXAMINER
Mar 19, 1998 DOCK